FDA-approved GLP-1 medications
FDA-approved medications are reviewed for safety, effectiveness, and manufacturing quality. They come with standardized dosing, labeling, storage requirements, and known safety warnings.
Compounded vs FDA-Approved GLP-1s: Safety & FDA Warnings | RMWL
Medication-Assisted Weight Loss
Compounded vs FDA-Approved GLP-1 Medications
Safety, sourcing, and what patients should know before starting treatment.
With the popularity of GLP-1 medications for weight management, many patients are now seeing offers for “compounded semaglutide” or “compounded tirzepatide” online. This page is here to help you understand the key differences and protect your safety.
At Rochester Medical Weight Loss, we believe obesity care should be physician-guided, monitored, and built on objective medical data, not a questionnaire, prescription, and subscription model.
The key difference
FDA-approved medications and compounded medications are not the same thing.
Compounded GLP-1 medications
Compounded medications are not FDA-approved. Compounding can be appropriate in limited situations, such as when a patient's medical needs cannot be met by an FDA-approved product or when an FDA-approved drug is not commercially available.
Compounded drugs do not go through the same FDA review for quality, safety, and effectiveness before they are sold.
Why this has become a big issue
Online marketing can make compounded GLP-1s sound simpler and safer than they may be.
Online companies have mass-marketed compounded GLP-1s as “equivalents” or “alternatives” to FDA-approved drugs. This can create confusion and may put patients at risk when important details are unclear.
- Dosing instructions use “units” instead of clear milligram-based directions.
- Concentration varies by compounding pharmacy or batch.
- Storage and shipping are inconsistent.
- Product labeling or sourcing is misleading.
This is one reason we emphasize in-person evaluation, baseline testing, and ongoing monitoring. Obesity treatment is medical care, not a product purchase.
FDA warnings and safety concerns
What patients should know before using a compounded GLP-1 product
The FDA has publicly raised multiple concerns with non-FDA-approved and compounded GLP-1 products. The biggest issues fall into a few categories.
Dosing errors
Some compounded products are dispensed in multi-dose vials with instructions in “units” rather than milligrams. FDA has reported dosing mistakes where patients received five to ten times more than intended.
Quality and concentration variability
Compounded products can vary by pharmacy and batch. Multiple concentrations can increase confusion for both patients and prescribers.
Shipping and storage problems
Injectable GLP-1 medications typically require refrigeration. The FDA has received complaints about compounded GLP-1 shipments arriving warm or without adequate cooling.
Semaglutide salt forms
The FDA has raised concerns about semaglutide sodium and semaglutide acetate because they are different ingredients than the active ingredient used in FDA-approved semaglutide products.
Fraudulent or misleading products
The FDA has warned about products sold online as “research use only” or “not for human consumption” that are still marketed to consumers with dosing instructions.
Increased enforcement
The FDA has announced enforcement steps and warning letters related to non-FDA-approved GLP-1 drugs and misleading marketing of compounded products.
Practical checklist
How to protect yourself as a patient
If you are considering GLP-1 therapy, or you are already using a compounded product, these green flags and red flags can help you know what to ask before taking the next dose.
Green flags
- You have a prescription from a licensed clinician.
- You fill through a state-licensed pharmacy.
- The label clearly states the drug, concentration, storage requirements, and beyond-use date.
- You receive dosing instructions in milligrams or mg/mL, not just “units.”
- Your provider is monitoring side effects, progress, and labs when appropriate.
Red flags
- “Research use only” or “not for human consumption” language.
- Unclear concentration or dosing instructions.
- Medication arrives warm or improperly packaged.
- The label has spelling errors, odd addresses, or unclear sourcing.
- Claims that the product is “the same as” or a “generic Wegovy/Zepbound” without being FDA-approved.
If anything feels questionable, pause and ask your clinician before using the product.
Already using a compounded GLP-1?
Don't panic, but don't guess.
Bring the vial, packaging, or clear photos of the label to your appointment so we can review the important details together.
Concentration
What is actually in the vial and at what strength?
Dosing instructions
Are instructions clear in milligrams or mg/mL?
Titration schedule
How quickly are doses being increased?
Storage requirements
Was the medication shipped and stored properly?
Side effects
What symptoms are showing up and when?
Safety monitoring
What follow-up and labs are appropriate?
If appropriate and available, we will discuss transitioning to an FDA-approved option and help you build a safer plan either way.
If GLP-1s are not right for you
You still have evidence-based options.
GLP-1s are a major advance, but they are not the only evidence-based tool and they are not right for everyone. Some patients cannot use them due to contraindications, side effects, cost or coverage barriers, or personal preference.
- Whole-food meal planning with physician guidance
- Structured meal replacement options when appropriate
- Other FDA-approved weight management medications when appropriate
- Body composition tracking to help protect lean mass
- Accountability and maintenance planning because obesity is chronic
Our approach
Medication should be part of a medically guided plan.
When medication is appropriate, Rochester Medical Weight Loss prioritizes safety, clarity, and long-term support.
FDA-approved options whenever possible
We prioritize medications that have gone through FDA review for safety, effectiveness, and manufacturing quality.
In-person evaluation and monitoring
Your treatment plan is based on your body, health history, goals, and follow-up needs.
Safe titration and side-effect support
Medication changes should be guided, not guessed.
Nutrition strategy and maintenance planning
Medication works best when paired with a plan for eating, habits, and long-term weight maintenance.
Progress beyond the scale
Body composition trends help us look at fat loss, muscle preservation, and metabolic health.
Clear sourcing and dosing
If compounding is ever considered, it should be for a specific clinical reason, with clear oversight.
Common questions
Compounded vs FDA-approved GLP-1 FAQs
Are compounded GLP-1 medications the same as FDA-approved medications?
No. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before they are marketed.
Why do dosing errors happen with compounded products?
Compounded products can come in different concentrations and may be dispensed in multi-dose vials with “units” dosing instructions. That creates confusion when patients measure doses themselves.
What should I do if my medication arrives warm?
Do not use it until you speak with your pharmacy and clinician. Temperature exposure can compromise quality.
Are semaglutide sodium or semaglutide acetate the same as semaglutide in FDA-approved products?
No. They are not the same ingredient as the active ingredient used in FDA-approved semaglutide products, and the FDA has raised concerns about their use.
If I am on a compounded GLP-1, should I switch?
At Rochester Medical Weight Loss, we do not support the use of compounded GLP-1 medication. We can review what you have been prescribed and talk through safer FDA-approved options when appropriate and available.
If GLP-1s are not an option for me, do I still have choices?
Yes. There are other evidence-based tools and strategies that can be personalized to your body and your life.
References and FDA sources
Have questions about GLP-1 safety?